Literature DB >> 22020029

Validation of the Essen Stroke Risk Score and the Stroke Prognosis Instrument II in Chinese patients.

Xia Meng1, Yilong Wang, Xingquan Zhao, Chunxue Wang, Hao Li, Liping Liu, Yong Zhou, Jie Xu, Yongjun Wang.   

Abstract

BACKGROUND AND
PURPOSE: Little was known about the predictive accuracy of the Essen Stroke Risk Score and the Stroke Prognostic Instrument II in Chinese patients with stroke.
METHODS: We evaluated the predictive accuracy of both Essen Stroke Risk Score and Stroke Prognostic Instrument II scores for both recurrent stroke and combined vascular events using data from a prospective cohort of 11 384 patients with acute ischemic stroke and transient ischemic attack admitted to 132 urban hospitals throughout China.
RESULTS: The cumulative 1-year event rates were 16% (95% CI, 15%-16%) for recurrent stroke and 18% (95% CI, 18%-19%) for combined vascular events. Both event rates were significantly higher in patients with transient ischemic attack and increased significantly from lower to higher Essen Stroke Risk Score and Stroke Prognostic Instrument II categories. Essen Stroke Risk Score and Stroke Prognostic Instrument II had similar predictive accuracies for each study outcome.
CONCLUSIONS: In Chinese patients with ischemic stroke or transient ischemic attack, both Essen Stroke Risk Score and Stroke Prognostic Instrument II scores are equally able to stratify the risk of recurrent stroke and combined vascular events.

Entities:  

Mesh:

Year:  2011        PMID: 22020029     DOI: 10.1161/STROKEAHA.111.624148

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Antiplatelet Strategies and Outcomes in Patients with Noncardioembolic Ischemic Stroke from a Real-World Study with a Five-Year Follow-Up.

Authors:  Huimin Xu; Yanting Ping; Haoran Lin; Ping He; Wenlu Li; Haibin Dai
Journal:  Transl Stroke Res       Date:  2016-12-31       Impact factor: 6.829

2.  Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study.

Authors:  Jiejie Li; Jinxi Lin; Yuesong Pan; Mengxing Wang; Xia Meng; Hao Li; Yilong Wang; Xingquan Zhao; Haiqiang Qin; Liping Liu; Yongjun Wang
Journal:  J Neuroinflammation       Date:  2022-06-06       Impact factor: 9.587

3.  Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.

Authors:  Walter N Kernan; Catherine M Viscoli; Jennifer L Dearborn; David M Kent; Robin Conwit; Pierre Fayad; Karen L Furie; Mark Gorman; Peter D Guarino; Silvio E Inzucchi; Amber Stuart; Lawrence H Young
Journal:  JAMA Neurol       Date:  2017-11-01       Impact factor: 18.302

4.  Increased recurrent risk did not improve cerebrovascular disease survivors' response to stroke in China: a cross-sectional, community-based study.

Authors:  Shengde Li; Li-Ying Cui; Craig Anderson; Chunpeng Gao; Chengdong Yu; Guangliang Shan; Longde Wang; Bin Peng
Journal:  BMC Neurol       Date:  2020-04-21       Impact factor: 2.474

5.  Essen score in the prediction of cerebrovascular events compared with cardiovascular events after ischaemic stroke or transient ischaemic attack: a nationwide registry analysis.

Authors:  Long Li; Ze-Ning Jin; Yue-Song Pan; Jing Jing; Xia Meng; Yong Jiang; Hao Li; Cai-Xia Guo; Yong-Jun Wang
Journal:  J Geriatr Cardiol       Date:  2022-04-28       Impact factor: 3.327

6.  Poststroke depression and risk of recurrent stroke at 1 year in a Chinese cohort study.

Authors:  Huai Wu Yuan; Chun Xue Wang; Ning Zhang; Ying Bai; Yu Zhi Shi; Yong Zhou; Yi Long Wang; Tong Zhang; Juan Zhou; Xin Yu; Xin Yu Sun; Zhao Rui Liu; Xing Quan Zhao; Yong Jun Wang
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

Review 7.  Formal and informal prediction of recurrent stroke and myocardial infarction after stroke: a systematic review and evaluation of clinical prediction models in a new cohort.

Authors:  Douglas D Thompson; Gordon D Murray; Martin Dennis; Cathie L M Sudlow; William N Whiteley
Journal:  BMC Med       Date:  2014-04-04       Impact factor: 8.775

8.  External Validation of Pooled Cohort Risk Equations to Predict 1-Year Clinical Outcome in Ischemic Stroke Patients.

Authors:  Haiyan Li; Runhua Zhang; Gaifen Liu; Liping Liu; Yilong Wang; Yongjun Wang
Journal:  Med Sci Monit       Date:  2017-09-13

Review 9.  Clinical Risk Score for Predicting Recurrence Following a Cerebral Ischemic Event.

Authors:  Durgesh Chaudhary; Vida Abedi; Jiang Li; Clemens M Schirmer; Christoph J Griessenauer; Ramin Zand
Journal:  Front Neurol       Date:  2019-11-12       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.